Original Research Article| Volume 101, ISSUE 5, P309-314, May 2020

Download started.


Sensitivity and specificity of placental proteins for gestational age screening: An exploratory study



      To examine the possibility that serum or urine concentrations of pregnancy-associated plasma protein A (PAPP-A), a disintegrin and metalloproteinase 12 (ADAM-12), placental growth factor (PlGF), human placental lactogen (HPL), glypican-3, pregnancy specific beta-1-glycoprotein 1 (PSG-1) or prolactin could predict gestational age (GA) >70 days, the currently recommended limit for medical abortion in the United States.

      Study design

      In this exploratory observational study, we collected serum and urine specimens from 245 healthy individuals with singleton intrauterine pregnancies at GA <40 weeks by ultrasound. We assayed the serum specimens for all seven proteins and the urine specimens for PAPP-A and ADAM-12. We used scatterplots and receiver operating characteristic curves to identify a concentration for each protein that would differentiate GAs above and below 70 days.


      All seven proteins showed significant ability to distinguish GAs >70 days from earlier gestations. A PAPP-A concentration ≥5.591 ng/ml provided 100% sensitivity and 90% specificity for identifying GAs >70 days. An ADAM-12 concentration of ≥3.11 ng/ml provided 98.5% sensitivity and 77% specificity for identifying GAs >70 days. Serum concentrations of the other compounds showed less diagnostic discrimination. PAPP-A was not detected in urine, and urinary ADAM-12 concentrations were not useful in identifying GAs above 70 days.


      PAPP-A and ADAM-12 showed considerable promise as bases for a sensitive and specific serum test for identifying pregnancies with GA >70 days. If these results are confirmed by future research, such a test could obviate the need for routine ultrasound before medical abortion.


      Two placental proteins, PAPP-A and ADAM-12, showed considerable promise as bases for a serum test for identifying pregnancies with gestational age >70 days. Such a test could be highly useful in screening patients for eligibility for medical abortion.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Folkersen J.
        • Grudzinskas J.G.
        • Hindersson P.
        • Teisner B.
        • Westergaard J.G.
        Pregnancy-associated plasma protein A: circulating levels during normal pregnancy.
        Am J Obstet Gynecol. 1981; 139: 910-914
        • Bischof P.
        • DuBerg S.
        • Herrmann W.
        • Sizonenko P.C.
        Pregnancy-associated plasma protein-A (PAPP-A) and hCG in early pregnancy.
        Br J Obstet Gynaecol. 1981; 88: 973-975
        • Laigaard J.
        • Sorensen T.
        • Frohlich C.
        • et al.
        ADAM12: a novel first-trimester maternal serum marker for Down syndrome.
        Prenat Diagn. 2003; 23: 1086-1091
        • Su Y.N.
        • Lee C.N.
        • Cheng W.F.
        • Shau W.Y.
        • Chow S.N.
        • Hsieh F.J.
        Decreased maternal serum placenta growth factor in early second trimester and preeclampsia.
        Obstet Gynecol. 2001; 97: 898-904
        • Ong C.Y.
        • Liao A.W.
        • Cacho A.M.
        • Spencer K.
        • Nicolaides K.H.
        First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction.
        Obstet Gynecol. 2001; 98: 608-611
        • Christiansen M.
        • Sorensen T.L.
        • Norgaard-Pedersen B.
        Human placental lactogen is a first-trimester maternal serum marker of Down syndrome.
        Prenat Diagn. 2007; 27: 1-5
        • Romero R.
        • Erez O.
        • Maymon E.
        • et al.
        The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.
        Am J Obstet Gynecol. 2017; 217: e1-e21
        • Westergaard J.G.
        • Teisner B.
        • Grudzinskas J.G.
        • Chard T.
        Accurate assessment of early gestational age by measuring serum hCG and SP1.
        Lancet. 1983; 2: 567-568
        • Xin G.
        • Wang M.
        • Jiao L.L.
        • Xu G.B.
        • Wang H.Y.
        Protein-to-creatinine ratio in spot urine samples as a predictor of quantitation of proteinuria.
        Clin Chim Acta. 2004; 350: 35-39
        • DeLong E.R.
        • DeLong D.M.
        • Clarke-Pearson D.L.
        Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
        Biometrics. 1988; 44: 837-845
        • Gonen M.
        Analyzing reciever operating characteristic curves with SAS.
        Sas Institute, Inc, Cary, NC2007 (Available from:
        • Bischof P.
        • Hughes G.
        • Klopper A.
        Relationship of obstetric parameters to the concentration of pregnancy-associated plasma protein A.
        Am J Obstet Gynecol. 1980; 138: 494-499
        • Spencer K.
        • Ong C.Y.
        • Liao A.W.
        • Nicolaides K.H.
        The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities.
        Prenat Diagn. 2000; 20: 491-494
        • Raymond E.G.
        • Grossman D.
        • Wiebe E.
        • Winikoff B.
        Reaching women where they are: eliminating the initial in-person medical abortion visit.
        Contraception. 2015; 92: 190-193
        • Raymond E.G.
        • Tan Y.L.
        • Comendant R.
        • et al.
        Simplified medical abortion screening: a demonstration project.
        Contraception. 2018; 97: 292-296
        • Kapp N.
        • Grossman D.
        • Jackson E.
        • Castleman L.
        • Brahmi D.
        A research agenda for moving early medical pregnancy termination over the counter.
        BJOG. 2017; 124: 1646-1652